Trial intelligence / Profile preview

Lidocaine formulations for episiotomy repair pain

PACTR201811710982025Phase 4Completed

Start
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of lidocaine in episiotomy pain (3 arms). Primary endpoint: Pain intensity during and after episiotomy repair. Started Nov 2018; status: completed.

02

Drugs

lidocaine
03

Conditions

episiotomy pain

Beyond the preview

Go deeper on PACTR201811710982025.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201811710982025.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call